Table of Contents
Volume 4 | Issue 4
Publication Date: January 2003- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
203-204 |
Adjuvant Therapy for Surgically Resected Non–Small-Cell Lung Cancer: Will It Become a Reality? Chandra P. Belani |
|
Meeting Highlights | ||
205-209 |
Highlights From: 27th Congress of the European Society for Medical Oncology, Nice, France Heather DeGrendele, Chandra P. Belani, Vinay K. Jain |
|
Researches in Brief | ||
210-212 |
Current Data with Bexarotene (Targretin®) in Non–Small-Cell Lung Cancer Heather DeGrendele, Chandra P. Belani, Harvey Pass |
|
213-216 |
Fluorodeoxyglucose Positron Emission Tomography as a Staging and Prognostic Tool in Non–Small-Cell Lung Cancer Heather DeGrendele, Chandra P. Belani, Ralph Naumann, Charles White |
|
Comprehensive Review | ||
217-223 |
Integration of Targeted Therapies in Gemcitabine Chemotherapy Regimens George R. Blumenschein, Jr., Roy S. Herbst |
|
Original Contribution | ||
224-228 |
A Phase II Study of Topotecan in Patients with Relapsed Small-Cell Lung Cancer Koji Takeda, Shunichi Negoro, Toshiyuki Sawa, Kazuhiko Nakagawa, Masaaki Kawahara, Takeshi Isobe, Shinzoh Kudoh, Noriyuki Masuda, Hisanobu Niitani, Masahiro Fukuoka |
|
Commentary | ||
229-230 |
Topotecan in Relapsed Small-Cell Lung Cancer: Can Good Things Come in Small Packages? John R. Eckardt |
|
Original Contribution | ||
231-236 |
Phase I/II Trial of the Safety and Efficacy of AE-941 (Neovastat®) in the Treatment of Non–Small-Cell Lung Cancer Jean Latreille, Gerald Batist, Francis Laberge, Pierre Champagne, Daniel Croteau, Pierre Falardeau, Carey Levinton, Claude Hariton, William K. Evans, Eric Dupont |
|
Translational Medicine | ||
237-241 |
Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients Carlos Camps, Carmen Sarries, Bárbara Roig, José Javier Sánchez, Cristina Queralt, Eva Sancho, Natividad Martinez, Miguel Tarón, Rafael Rosell |
|
Imaging in Lung Cancer | ||
242-247 |
Additional Value of Whole-Body Fluorodeoxyglucose Positron Emission Tomography in the Detection of Distant Metastases of Non–Small-Cell Lung Cancer Sigrid G. Stroobants, Isabelle D’Hoore, Christophe Dooms, Paul R. De Leyn, Patrick J. Dupont, Walter De Wever, Tjibbe De Groot, Johny A. Verschakelen, Luc A. Mortelmans, Johan F. Vansteenkiste |
|
Commentary | ||
248 |
Diagnostic Imaging and Other Tools in the Detection of Lung Cancer James D. Luketich |
|
Case Report | ||
249-251 |
Amyloidosis and Lung Cancer J. Ramón Barceló, Alberto Muñoz, Joan M. Mañé, Itziar Rubio, Teresa Pérez-Hoyos, Ainhoa Viteri, Guillermo M. López-Vivanco |
|
Commentary | ||
252 |
Amyloidosis and Cancer Mehdi Farhangi |
|